Efficacy and safety of first-line biological DMARDs in rheumatoid arthritis patients with chronic kidney disease. Yoshimura Y, Yamanouchi M, Mizuno H, Ikuma D, et al. Ann Rheum Dis 2024 Jul 4:ard-2024-225914. doi: 10.1136/ard-2024-225914.

Read + Share

Amedeo Smart

Independent Medical Education

Yoshimura Y, Yamanouchi M, Mizuno H, Ikuma D, et al. Efficacy and safety of first-line biological DMARDs in rheumatoid arthritis patients with chronic kidney disease. Ann Rheum Dis 2024 Jul 4:ard-2024-225914. doi: 10.1136/ard-2024-225914.
PMID: 38964755